Literature DB >> 7979986

Sequence variation of the amino-terminal antigenic domains of glycoprotein B of human cytomegalovirus strains isolated from Chinese patients.

S Y Shiu1, K M Chan, S K Lo, K W Ip, K Y Yuen, R B Health.   

Abstract

To study the genetic variation of human cytomegalovirus (HCMV) in Asian populations, the amino-terminal antigenic domains of glycoprotein B of HCMVs isolated from ethnic Chinese transplant patients were cloned and sequenced. The nucleotide and encoded amino acid sequences were compared with published sequences of AD169 and Towne laboratory strains. Within the region sequenced, 9 out of 15 clinical isolates (60%) possessed a peptide configuration similar to that of strain AD169 while 6 isolates (40%) displayed a peptide configuration similar to that of strain Towne. The nucleotide and amino acid identities of AD169-like clinical isolates exhibited variations of 95.4%-99.6% and 95.4%-100% respectively, whereas the identities of Towne-like clinical isolates were within the range of 97.3%-100% and 96.6%-100% at the nucleotide and amino acid levels. The previously defined neutralizing epitope was conserved among the clinical isolates sequenced while unique non-conservative amino acid substitutions were detected in the non-neutralizing epitope within the amino-terminal antigenic domain of glycoprotein B of all AD169-like isolates (Y- > S) and one of the Towne-like isolates (R- > Q).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979986     DOI: 10.1007/BF01311179

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus.

Authors:  S Chou
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes.

Authors:  S W Chou; K M Dennison
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Comparative sequence analysis of human cytomegalovirus strains.

Authors:  R Lehner; T Stamminger; M Mach
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage.

Authors:  R R Spaete; R M Thayer; W S Probert; F R Masiarz; S H Chamberlain; L Rasmussen; T C Merigan; C Pachl
Journal:  Virology       Date:  1988-11       Impact factor: 3.616

Review 5.  Prospects for the clinical management of human cytomegalovirus infections.

Authors:  G H Farrar; J R Bull; P J Greenaway
Journal:  Vaccine       Date:  1986-12       Impact factor: 3.641

6.  Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays.

Authors:  N E Cremer; C K Cossen; G R Shell; L Pereira
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

7.  Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.

Authors:  W J Britt; L Vugler; E J Butfiloski; E B Stephens
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope.

Authors:  H Meyer; Y Masuho; M Mach
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

9.  Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans.

Authors:  L Rasmussen; C Matkin; R Spaete; C Pachl; T C Merigan
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

10.  Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Authors:  M P Cranage; T Kouzarides; A T Bankier; S Satchwell; K Weston; P Tomlinson; B Barrell; H Hart; S E Bell; A C Minson
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  2 in total

1.  Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain.

Authors:  M Porta; N Malats; E Morell; G Gomez; M Gallén; F Macià; M Casamitjana; X Fabregat
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

2.  Classification of human Herpesviridae proteins using Domain-architecture Aware Inference of Orthologs (DAIO).

Authors:  Christian M Zmasek; David M Knipe; Philip E Pellett; Richard H Scheuermann
Journal:  Virology       Date:  2019-01-06       Impact factor: 3.616

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.